Clinical trial
Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration
NCT04241536 is registered in ClinicalTrials.gov with Association for Innovation and Biomedical Research on Light and Image as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration
- Lead sponsor
- Association for Innovation and Biomedical Research on Light and Image
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 1, 2021
- Completion date
- November 29, 2022
- Enrollment
- 295 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age-related macular degeneration